2020
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease
Zheng XZ, Qin XY, Chen SW, Wang P, Zhan Y, Zhong PP, Buza N, Jin YL, Wu BQ, Hui P. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Modern Pathology 2020, 33: 1979-1988. PMID: 32404958, DOI: 10.1038/s41379-020-0566-4.Peer-Reviewed Original ResearchConceptsNon-molar gestationsGestational trophoblastic diseaseTrophoblastic diseaseHigh riskGestational trophoblastic neoplasiaProducts of conceptionPatient demographicsClinical followClinical outcomesGynecology HospitalTrophoblastic neoplasiaBeijing ObstetricsFIGO criteriaChinese patientsClinical prognosisPatient managementLarge cohortGestationMolar gestationDiseaseGenetic abnormalitiesChromosomal monosomyChromosomal aneuploidyHydatidiformUniparental disomy
2011
Molecular Diagnosis of Gestational Trophoblastic Disease
Hui P. Molecular Diagnosis of Gestational Trophoblastic Disease. Current Clinical Pathology 2011, 161-178. DOI: 10.1007/978-1-61779-394-3_11.Peer-Reviewed Original ResearchMinimal histological abnormalitiesGestational trophoblastic diseaseAvailable ancillary studiesGestational trophoblastic disordersNormal pregnancyHistological diagnosisTrophoblastic diseaseGynecological pathologyHistological abnormalitiesAncillary studiesTrophoblastic disordersComplete hydatidiformPartial hydatidiformDaily practiceDiagnosisHydatidiformMolecular diagnosisSignificant percentagePathologistsHydropic abortus